Public health practitioners combine proven interventions to tackle complex health challenges using new framework
Peer-Reviewed Publication
Updates every hour. Last Updated: 30-May-2026 03:15 ET (30-May-2026 07:15 GMT/UTC)
Vast resources have gone into developing and testing medical and public health interventions so they can be used confidently as evidence-based practices. Yet many interventions are deployed in isolation—even when the people they aim to help often face multiple, overlapping health challenges. A new study led by researchers at Columbia School of Public Health introduces an innovative method designed to increase the use and impact of evidence-based practices by combining them into stronger, multi-component programs.
Researchers review how hydrogel-based wearable devices can collect and analyze sweat to monitor health biomarkers like glucose, lactate, and electrolytes. These flexible, biocompatible sensors offer a non-invasive alternative to blood tests for real-time health tracking.
We all know stress can worsen pain, but new research shows that anger and a sense of injustice may be even more powerful triggers. In a study of more than 700 people living with chronic pain, researchers uncovered four distinct “anger profiles” that help explain why some patients hurt more, and longer, than others. Those who felt wronged or unfairly treated by their condition were the most likely to report severe, persistent pain months later. The findings suggest that learning to understand and manage anger could be essential to healing.
Researchers have discovered a novel role of Neuraminidase 1 (NEU1) in the pathophysiology of acute lung injury (ALI) and uncovers NEU1 as a direct target of baicalin and Huanglian Jiedu Decoction (HLJDD) in alleviating ALI. NEU1 binding to the CXCR4 protein, thereby activating the downstream JNK signaling pathway, promoting inflammation and endothelial barrier damage; whereas baicalin can enhance the degradation of NEU1 protein via the lysosomal pathway, thereby improving endothelial dysfunction and acute lung injury.
Antimicrobial peptides (AMPs) exhibit broad-spectrum antimicrobial activity, low propensity to induce bacterial resistance, and multifunctional properties including immunomodulation and tissue regeneration promotion.This study comprehensively reviews the classification, antimicrobial mechanisms, and therapeutic applications of AMPs in major oral diseases such as dental caries, periodontitis, oral cancer, oral candidiasis, and oral mucositis. The research also analyzes key challenges in clinical translation (stability, cytotoxicity, immunogenicity, production costs) and corresponding solutions, while exploring their applications in implant coatings, oral dressings, combination therapy, and diagnostic markers, providing a robust theoretical basis for advancing oral disease treatment.